GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -774 | -4,940 | -1,922 | -1,269 | -690 |
| Depreciation Amortization | 212 | 467 | 201 | 102 | 50 |
| Income taxes - deferred | N/A | -12 | N/A | N/A | N/A |
| Accounts receivable | -88 | 133 | -29 | -65 | -137 |
| Accounts payable and accrued liabilities | 5 | 64 | 225 | 176 | 159 |
| Other Working Capital | 307 | 811 | 769 | 155 | 10 |
| Other Operating Activity | 324 | 2,806 | 250 | 155 | 123 |
| Operating Cash Flow | $-14 | $-671 | $-506 | $-746 | $-485 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -64 | -64 | -38 | -7 |
| Purchase Of Investment | N/A | -3,060 | -3,060 | -3,060 | -3,060 |
| Sale Of Investment | 3,060 | 3,060 | 3,060 | 3,060 | 3,060 |
| Purchase Sale Intangibles | N/A | -44 | -42 | -32 | -3 |
| Other Investing Activity | 0 | -44 | -42 | -32 | -3 |
| Investing Cash Flow | $3,059 | $-108 | $-106 | $-70 | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 3,666 | 3,666 | 3,660 | 3,660 |
| Debt Repayment | N/A | 1,350 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 70 | 69 | 63 | N/A |
| Other Financing Activity | -3,060 | -3,713 | -3,060 | -3,060 | -3,060 |
| Financing Cash Flow | $-3,060 | $1,373 | $675 | $663 | $600 |
| Beginning Cash Position | 1,208 | 614 | 614 | 614 | 614 |
| End Cash Position | 1,193 | 1,208 | 677 | 461 | 719 |
| Net Cash Flow | $-15 | $594 | $63 | $-153 | $105 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14 | -671 | -506 | -746 | -485 |
| Capital Expenditure | -1 | -64 | -64 | -38 | -7 |
| Free Cash Flow | -15 | -735 | -570 | -784 | -492 |